Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: a National Population-Based Cohort Study

• In a nationwide AML cohort, HSCT improves survival compared to chemotherapy-only• The anti-leukemic effect of HSCT in CR1 reduces relapse rates and increase RFS• Both intermediate and adverse cytogenetic risk patients benefit from HSCT in CR1• Superior outcomes in younger (

Source: Biology of Blood and Marrow Transplantation - October 16, 2017 Category: Hematology Authors: Lene Sofie Granfeldt Østgård, Jennifer L. Lund, Jan Maxwell Nørgaard, Mette Nørgaard, Bruno C. Medeiros, Bendt Nielsen, Ove Juul Nielsen, Ulrik Malthe Overgaard, Maria Kallenbach, Claus Werenberg Marcher, Anders Hammerich Riis, Henrik Sengeløv Source Type: research